Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision from v3.2.0 to v3.3.2 appears on the page, a minor update that does not affect study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA government funding/status notice was removed from the page. No other content changes are visible.SummaryDifference0.4%

- Check42 days agoChange DetectedThe study details appear unchanged between the two screenshots; there are no updates to enrollment, outcomes, or contact information.SummaryDifference0.5%

- Check71 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

- Check78 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference0.4%

- Check92 days agoChange DetectedUpdated revision tag from v3.0.1 to v3.0.2; removed 'Back to Top' link. No substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.